Quantitative Investment Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-262,429
Closed -$26.1M 851
2019
Q3
$26.1M Buy
+262,429
New +$24.9M 1.39% 6
2019
Q1
Sell
-32,300
Closed -$2.07M 920
2018
Q4
$2.07M Buy
+32,300
New +$2.38M 0.11% 184
2017
Q4
Sell
-322,900
Closed -$47.1M 952
2017
Q3
$47.1M Sell
322,900
-163,900
-34% -$22.3M 0.54% 31
2017
Q2
$63.2M Buy
486,800
+429,700
+753% +$52.7M 0.95% 10
2017
Q1
$7.1M Buy
+57,100
New +$6.83M 0.11% 260
2016
Q2
Sell
-7,700
Closed -$770K 1053
2016
Q1
$770K Sell
7,700
-37,300
-83% -$3.84M 0.04% 458
2015
Q4
$5.39M Buy
+45,000
New +$5.21M 0.33% 69
2015
Q3
Sell
-36,400
Closed -$4.21M 872
2015
Q2
$4.21M Buy
+36,400
New +$4.16M 0.63% 34
2015
Q1
Sell
-33,200
Closed -$3.71M 833
2014
Q4
$3.71M Buy
+33,200
New +$3.5M 0.57% 37
2014
Q3
Sell
-10,800
Closed -$927K 628
2014
Q2
$927K Buy
+10,800
New +$821K 0.17% 125
2013
Q4
Sell
-24,000
Closed -$1.85M 817
2013
Q3
$1.85M Buy
24,000
+2,000
+9% +$140K 0.16% 126
2013
Q2
$1.29M Buy
+22,000
New +$1.32M 0.23% 98

Other funds holding CELG

Quantitative Investment Management's CELG Position: Q4 2019 in Review

Quantitative Investment Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 262,429 shares — an estimated $26.1M sold.

Quantitative Investment Management first reported a position in CELG in Q2 2013 and held it in 12 quarters. The position peaked at $63.2M in Q2 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Quantitative Investment Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Quantitative Investment Management sold 262,429 Celgene Corp shares in Q4 2019, an estimated $26.1M.
  • Quantitative Investment Management first reported a position in Celgene Corp in Q2 2013 and held it in 12 quarters.
  • Quantitative Investment Management's Celgene Corp position peaked at $63.2M in Q2 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Quantitative Investment Management's 13F filing for Q4 2019, filed 14 Feb 2020.